Wenfeng Liu
Zhongshan, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Author Correction: Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.
Journal: Nature cancer
Published: August 26, 2026
Cancer-associated fibroblast miR-148a-5p/CALD1/collagen VI pathway promotes proliferation in Helicobacter pylori-positive gastric cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: June 23, 2025
Alisertib impairs the stemness of hepatocellular carcinoma by inhibiting purine synthesis.
Journal: The Journal of biological chemistry
Published: February 06, 2025
Increased CAPG inhibits ferroptosis to drive tumor proliferation and sorafenib resistance in hepatocellular carcinoma via the WDR74-p53-SLC7A11 pathway.
Journal: International journal of biological sciences
Published: February 02, 2025
GPR34 inhibition reprograms tumor-associated macrophages and enhances the sensitivity of anti-PD-1 therapy in hepatocellular carcinoma.
Journal: Cancer cell international
Published: January 25, 2025
Activation of NOD1 on tumor-associated macrophages augments CD8+ T cell-mediated antitumor immunity in hepatocellular carcinoma.
Journal: Science advances
Published: October 02, 2024
Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: December 11, 2023
Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
Journal: Therapeutic advances in medical oncology
Published: September 29, 2023
LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.
Journal: American journal of cancer research
Published: August 25, 2023
Development and Preliminary Validation of a Novel Convolutional Neural Network Model for Predicting Treatment Response in Patients with Unresectable Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.
Journal: Journal of imaging informatics in medicine
Published: August 22, 2023
NLRP3/IL-1β induced myeloid-derived suppressor cells recruitment and PD-L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma.
Journal: MedComm
Published: April 22, 2023
Last Updated: 09/26/2026